Smoking cessation

Stephen I. Rennard, David M. Daughton

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse.

Original languageEnglish (US)
Pages (from-to)165-176
Number of pages12
JournalClinics in Chest Medicine
Volume35
Issue number1
DOIs
StatePublished - Mar 2014

Keywords

  • Cessation
  • Pharmacotherapy
  • Smoking
  • Treatment

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Smoking cessation'. Together they form a unique fingerprint.

  • Cite this

    Rennard, S. I., & Daughton, D. M. (2014). Smoking cessation. Clinics in Chest Medicine, 35(1), 165-176. https://doi.org/10.1016/j.ccm.2013.11.002